Bioterrorism : Market Research Report

Bioterrorism

Published by: Global Industry Analysts

Published: Jul. 1, 2009

I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS: Study Reliability and Reporting Limitations; Disclaimers; Quantitative Techniques & Analytics
II. EXECUTIVE SUMMARY: 1.INTRODUCTION; 2.UNDERSTANDING BIOTERRORISM; Why Biological Agents?; Properties of Biological Agents with Potential for Use asWeapons of Mass Destruction; Anthrax; Types of Anthrax; Smallpox; Plague; Pneumonic Plague; Tularemia; The Tularemia History; Marburg Hemorrhagic Fever; Q Fever; Brucellosis; Ricin; 3.MODES OF DELIVERY; Other; 4.BIOTERRORISM DEFENSE PRODUCTS ANDDETECTION EQUIPMENT; Personal Protective Equipment; 5.RECENT INDUSTRY ACTIVITY; Johnson & Johnson to Acquire Omrix; Universal Detection and Kadinuo Sign Agreement; Innovative Biosensors and Universal DetectionPlan Collaboration; Universal Detection Secures Repeat Order forBiodetection Kits; Hawaii Emergency Medical Services Orders Simulationand Bio-Detection Kits; NanoSensors to Acquire DKL International; CytoGenix Enters into CRADA with USAMRIID; Emergent BioSolutions Signs Agreement to LicenseVaxImmune; AVI BioPharma Secures Bioterrorism ResponseTherapies Contracts; SRI International Secures Contract for Anti-BiologicalThreat Drugs from DTRA; Ibis Biosciences Receives Four New Contractsfrom Government; PharmAthene Receives Contract to Develop AnthraxAnti-Toxin; Universal Detection Commences R&D for PortableAnthrax Detector; 6.PRODUCT LAUNCHES; Innovative Biosensors Unveils BioFlash BiologicalDetector; 7.FOCUS ON SELECT PLAYERS; Human Genome Sciences Inc. (USA); Medarex, Inc. (USA); Scott Health & Safety (USA); Universal Detection Technology (USA); 8.GLOBAL MARKET PERSPECTIVE; Table 2: World Historic Review for Bioterrorism Detection Equipment by Geographic Region - US, Europe, Asia(Including Japan), and Middle East Markets Independently Analyzed with Annual Revenues in US$ Million forYears 2001 through 2015 (includes correspondingGraph/Chart)
III. MARKET: 1.THE UNITED STATES; Market Drivers; Government Biodefense Funding; Table 4: The US Federal Government Spending on Bioweapons Prevention and Defense - Allocation of Funds in US$ Million by Department/Agency from FY2001 to FY2007 (includes corresponding Graph/Chart); Table 5: The US Federal Government Spending on Bioweapons Prevention and Defense - PercentageShare Breakdown of Funds Allocation by Department/Agency for FY2001 and FY2007(includes corresponding Graph/Chart); Table 6: The US Federal Funding for the Departmentof Health and Human Services by its Constituent Agencies and Offices in US$ Million from FY2001-FY2007 (Including Requested Funding for the Year 2007) (includes corresponding Graph/Chart); Table 7: Biodefense Funding for Research,Development, Testing and Evaluation (RTD&E)by Agency/Department in US$ Million fromFY2001 to FY2007; Biodefense Prevention Funding; Government Biodefense Initiatives; Pandemic and All-Hazards Preparedness Act; The National Institutes of Health; The CDC Regulated Shipment Agents; The Department of Defense; B. Market Analytics; Table 11: US Recent Past, Current & Future Analysisfor Bioterrorism Vaccines Market - Annual Revenuein US$ Million for Years 2006 through 2015(includes corresponding Graph/Chart); 2.EUROPE; Table 14: European Historic Review for Bioterrorism Detection Equipment Market - Annual Revenuein US$ Million for Years 2001 through 2005(includes corresponding Graph/Chart); 3.ASIA; B. Market Analytics; 4.THE MIDDLE EAST; Table 18: The Middle East Historic Review forBioterrorism Detection Equipment Market - AnnualRevenue in US$ Million for Years 2001 through2005 (includes corresponding Graph/Chart)
IV. COMPETITIVE LANDSCAPE: Total Companies Profiled: 66 (including Divisions/Subsidiaries - 67); Region/Country Players; The United States; Canada; Europe; Asia-Pacific (Excluding Japan); Middle East

Abstract

This report analyzes the worldwide markets for Bioterrorism in Millions of US$. The report provides separate comprehensive analytics for the US, Europe, Asia, and Middle East. Annual forecasts are provided for each region for the period of 2001 through 2015. The report profiles 66 companies including many key and niche players worldwide such as Acambis Plc., AVI BioPharma, Inc., Bl�cher Gmbh, Evogen, Inc., Human Genome Sciences Inc., ICX Technologies, Inc., ILC Dover LP, Medarex, Inc., Northrop Grumman Corporation, PharmAthene, Inc., Scott Health & Safety, Smiths Detection, The Baker Company, Universal Detection Technology and Universal Detection Technology. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your reading room immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Bioterrorism

Table of Contents

Abstract